نمایش پرونده ساده آیتم

dc.contributor.authorMaleki, D
dc.contributor.authorHomayouni, A
dc.contributor.authorKhalili, L
dc.contributor.authorGolkhalkhali, B
dc.date.accessioned2018-08-26T09:32:51Z
dc.date.available2018-08-26T09:32:51Z
dc.date.issued2015
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/57429
dc.description.abstractA probiotic is defined as a live microorganism that, when ingested in adequate amounts, exerts a health benefit to the host. Probiotics have been documented to exert anticarcinogenic properties and prevention of cancer by several mechanisms, including the stimulation of the immune system, decreasing the incidence of infections, regulating gut inflammation, and binding toxic compounds. This chapter analyzes existing data from animal and human studies to highlight the therapeutic and preventive effects of probiotics in cancer. We researched Science Direct by using "probiotics," "cancer," and "prevention" to search for studies of the application of probiotics and the beneficial effects of probiotics in cancer control and treatment. A number of studies indicated that administration of bifidobacteria or lactobacilli alone or with fermentable carbohydrates (prebiotics) can alter colonic microbiota and decrease the development of early preneoplastic lesions and tumors and may be related to a lower incidence of cancer. é 2016 Elsevier Inc.
dc.language.isoEnglish
dc.relation.ispartofProbiotics, Prebiotics, and Synbiotics: Bioactive Foods in Health Promotion
dc.titleProbiotics in Cancer Prevention, Updating the Evidence
dc.typeArticle
dc.citation.spage781
dc.citation.epage791
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.1016/B978-0-12-802189-7.00059-9


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم